Abstract
Plasma-prolactin levels doubled in depressive patients treated with the monoamine-oxidase inhibitors, clorgyline and pargyline. The absence of significant changes in plasma-cortisol in the same patients suggests that the increases in prolactin are not attributable to non-specific effects of stress.
Publication types
-
Clinical Trial
-
Comparative Study
-
Controlled Clinical Trial
MeSH terms
-
Clorgyline / pharmacology*
-
Clorgyline / therapeutic use
-
Depression / drug therapy
-
Female
-
Humans
-
Hydrocortisone / blood
-
Male
-
Pargyline / pharmacology*
-
Pargyline / therapeutic use
-
Placebos
-
Prolactin / blood*
-
Propylamines / pharmacology*
Substances
-
Placebos
-
Propylamines
-
Prolactin
-
Pargyline
-
Clorgyline
-
Hydrocortisone